Evidence map›Paper›PMID 26418335›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2015

Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.

Brent M Molden, Kimberly A Cooney, Kirk West, Lex H T Van Der Ploeg, Giulia Baldini

Abstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Agonism and Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brent M MoldenDepartment of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
Kimberly A CooneyDepartment of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
Kirk WestDepartment of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
Lex H T Van Der PloegDepartment of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
Giulia BaldiniDepartment of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.

Funding

The University of Arkansas for Medical Sciences Initiative for Maximizing Student Development ProgramR25GM083247 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI MCGEHEE, ROBERT E, THOMAS, BILLY R · 2009 to 2023
$5.4M
Lipid Stress and MC4R - RevisionR01DK102206 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI BALDINI, GIULIA · 2014 to 2018
$1.8M
Melanocortin-4 Receptor Traffic and SignalingR01DK080424 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI BALDINI, GIULIA · 2009 to 2012
$1.3M
Mechanism of the desensitization of MC4RF30DK095569 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI MOLDEN, BRENT MATTHEW · 2012 to 2014
$120k
NIDDK NIH HHS F30 DK095569NIDDK NIH HHS R01 DK080424NIDDK NIH HHS R01-DK080424NIDDK NIH HHS R01 DK102206NIDDK NIH HHS R01-DK102206NIGMS NIH HHS R25 GM083247
6 · The paper itself

Abstract

The melanocortin-4 receptor (MC4R) is a G protein-coupled receptor expressed in the brain, where it controls energy balance through pathways including α-melanocyte-stimulating hormone (α-MSH)-dependent signaling. We have reported that the MC4R can exist in an active conformation that signals constitutively by increasing cAMP levels in the absence of receptor desensitization. We asked whether synthetic MC4R agonists differ in their ability to increase intracellular cAMP over time in Neuro2A cells expressing endogenous MC4R and exogenous, epitope-tagged hemagglutinin-MC4R-green fluorescent protein. By analyzing intracellular cAMP in a temporally resolved Förster resonance energy transfer assay, we show that withdrawal of α-MSH leads to a quick reversal of cAMP induction. By contrast, the synthetic agonist melanotan II (MTII) induces a cAMP signal that persists for at least 1 hour after removal of MTII from the medium and cannot be antagonized by agouti related protein. Similarly, in mHypoE-42 immortalized hypothalamic neurons, MTII, but not α-MSH, induced persistent AMP kinase signal, which occurs downstream of increased cAMP. By using a fluorescence recovery after photobleaching assay, it appears that the receptor exposed to MTII continues to signal after being internalized. Similar to MTII, the synthetic MC4R agonists, THIQ and BIM-22511, but not LY2112688, induced prolonged cAMP signaling after agonist withdrawal. However, agonist-exposed MC4R desensitized to the same extent, regardless of the ligand used and regardless of differences in receptor intracellular retention kinetics. In conclusion, α-MSH and LY2112688, when compared with MTII, THIQ, and BIM-22511, vary in the duration of the acute cAMP response, showing distinct temporal signaling selectivity, possibly linked to specific cell compartments from which cAMP signals may originate.

Indexed as

Adenylate KinaseAgouti-Related Proteinalpha-MSHAMP-Activated Protein KinasesAnimalsCell LineCyclic AMPFluorescence Resonance Energy TransferGreen Fluorescent ProteinsMicePeptidesPeptides, CyclicPhotobleachingProtein ConformationReceptor, Melanocortin, Type 4TetrahydroisoquinolinesAdenylate KinaseAgouti-Related Proteinalpha-MSHAMP-Activated Protein KinasesCyclic AMPGreen Fluorescent ProteinsLY2112688MC4R protein, mousemelanotan-IIN-(1,2,3,4-tetrahydroisoquinolinium-3-ylcarbonyl)-1-(4-chlorobenzyl)-2-(4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl)-2-oxoethylaminePeptidesPeptides, CyclicReceptor, Melanocortin, Type 4TetrahydroisoquinolinesTriazoles

Identifiers

PMID26418335
PMCPMC4627605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.